Clinical Trial: A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329621) titled 'A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults' on Dec. 19, 2025.

Brief Summary: This study is to see how well MSP-2020 attaches to specific targets in the brain called serotonin type 2A receptors (5-HT2AR). This study will also look at how much of the study drug (and its active metabolite) is in the blood and how long the study drug stays in the blood, as well as the safety of MSP 2020.

Study Start Date: Jan. 05

Study Type: INTERVENTIONAL

Condition: Incomplete Response - Major Depressive Disorder (IR-MDD)

Intervention: DRUG: MSP-2020

capsule

Recruitment Status: N...